Medtech company Catalyst OrthoSciences has received FDA 510(k) clearance for its Archer Patient-Specific Instrumentation.
The shoulder arthroplasty technology is a suite of humeral and glenoid guides that helps orthopedic surgeons improve precision, consistency and confidence, according to a Feb. 25 news release from Catalyst.
Archer PSI is indicated for anatomic and reverse shoulder procedures.
The company has launched a limited market release of Archer PSI to guide optimization before a commercial launch, the release said.
